HK1148932A1 - Method to ameliorate oxidative stress and improve working memory via pterostilbene administration - Google Patents

Method to ameliorate oxidative stress and improve working memory via pterostilbene administration

Info

Publication number
HK1148932A1
HK1148932A1 HK11101728A HK11101728A HK1148932A1 HK 1148932 A1 HK1148932 A1 HK 1148932A1 HK 11101728 A HK11101728 A HK 11101728A HK 11101728 A HK11101728 A HK 11101728A HK 1148932 A1 HK1148932 A1 HK 1148932A1
Authority
HK
Hong Kong
Prior art keywords
oxidative stress
working memory
improve working
memory via
pterostilbene
Prior art date
Application number
HK11101728A
Other languages
English (en)
Inventor
James A Joseph
Agnes M Rimando
Barbara Shukitt-Hale
Original Assignee
Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us filed Critical Us
Publication of HK1148932A1 publication Critical patent/HK1148932A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11101728A 2007-09-07 2011-02-22 Method to ameliorate oxidative stress and improve working memory via pterostilbene administration HK1148932A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97059107P 2007-09-07 2007-09-07
US12/136,341 US20090069444A1 (en) 2007-09-07 2008-06-10 Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration
PCT/US2008/075170 WO2009032870A2 (en) 2007-09-07 2008-09-04 Method to ameliorate oxidative stress and improve working memory via pterostilbene administration

Publications (1)

Publication Number Publication Date
HK1148932A1 true HK1148932A1 (en) 2011-09-23

Family

ID=40429677

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11101728A HK1148932A1 (en) 2007-09-07 2011-02-22 Method to ameliorate oxidative stress and improve working memory via pterostilbene administration
HK13112566.4A HK1185257A1 (zh) 2007-09-07 2013-11-08 通過施用紫檀芪減輕氧化應激並改善工作記憶的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK13112566.4A HK1185257A1 (zh) 2007-09-07 2013-11-08 通過施用紫檀芪減輕氧化應激並改善工作記憶的方法

Country Status (11)

Country Link
US (3) US20090069444A1 (xx)
EP (1) EP2200597B1 (xx)
JP (1) JP5608082B2 (xx)
KR (1) KR20100075468A (xx)
CN (2) CN101820869B (xx)
AU (1) AU2008296293A1 (xx)
BR (1) BRPI0816317A2 (xx)
CA (1) CA2698661C (xx)
ES (1) ES2526648T3 (xx)
HK (2) HK1148932A1 (xx)
WO (1) WO2009032870A2 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090069444A1 (en) * 2007-09-07 2009-03-12 The United States Of America, As Represented By Th E Secretary Of Agriculture Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration
US9737495B2 (en) * 2009-06-22 2017-08-22 Indus Biotech Private Limited Process for obtaining purified pterostilbene and methods of use thereof
US20100119499A1 (en) * 2009-09-17 2010-05-13 Kneller Bruce W Stilbene-based compositions and methods of use therefor
US20110280850A1 (en) * 2010-05-12 2011-11-17 Starr Elizabeth I Compositions Containing DNA Repair Enzyme And Anogeissus Extract
US20120237494A1 (en) * 2010-09-30 2012-09-20 Daly Susan M Compositions Containing Zinc PCA And Anogeissus Extract
EP2537513A3 (en) * 2011-03-11 2015-04-29 ELC Management LLC Use of anogeissus extract for fibrillin production in skin
US9439875B2 (en) * 2011-05-11 2016-09-13 The United States Of America, As Represented By The Secretary Of Agriculture Anxiolytic effect of pterostilbene
US20130072509A1 (en) * 2011-09-15 2013-03-21 ChromaDex Inc. Pterostilbene and statin combination for treatment of metabolic disease, cardiovascular disease, and inflammation
WO2013051459A1 (ja) * 2011-10-02 2013-04-11 キユーピー 株式会社 ＲＮＡ干渉によるｍＲＮＡ発現の抑制を促進する促進剤およびその用途
JP5901547B2 (ja) 2012-03-28 2016-04-13 富士フイルム株式会社 組成物、これを含む皮膚外用剤、又は機能性食品
MX2021009652A (es) 2013-10-30 2022-07-26 Chromadex Inc Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel.
WO2017011318A1 (en) 2015-07-10 2017-01-19 University Of Miami Methods for treating mucopolysaccharidosis
AU2017316614B2 (en) 2016-08-22 2023-06-15 Elysium Health, Inc. Nicotinamide riboside and pterostilbene compositions and methods for treatment of neurodegenerative disorders
WO2018089830A1 (en) 2016-11-11 2018-05-17 The Queen's University Of Belfast Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
MX2019006278A (es) 2016-11-29 2019-08-21 Univ Iowa Res Found Uso de precursores de nad para mejorar la salud materna y/o salud de la descendencia.
SG11202010115RA (en) * 2018-05-15 2020-11-27 Alkahest Inc Treatment of aging-associated disease with modulators of leukotriene a4 hydrolase
JP7345312B2 (ja) * 2019-08-09 2023-09-15 キユーピー株式会社 発酵乳
WO2022065910A1 (ko) 2020-09-25 2022-03-31 씨제이제일제당 (주) 스틸벤계 화합물을 포함하는 항콕시듐증 조성물 및 이의 용도
CN112618520A (zh) * 2021-01-14 2021-04-09 姚大纯 紫檀芪或白藜芦醇在制备用于治疗或改善孤独症谱系障碍的药物中的应用
EP4426284A1 (en) 2021-11-01 2024-09-11 Alkahest, Inc. Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038125A1 (en) * 2003-08-15 2005-02-17 Smit Hobbe Friso Method for the treatment of arthritis and pain
JP4633572B2 (ja) * 2004-07-30 2011-02-16 イスクラ産業株式会社 糖尿病改善剤
US20060057231A1 (en) * 2004-08-19 2006-03-16 Rimando Agnes M Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform
US20090069444A1 (en) * 2007-09-07 2009-03-12 The United States Of America, As Represented By Th E Secretary Of Agriculture Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration

Also Published As

Publication number Publication date
CN103083288B (zh) 2016-04-13
US20090069444A1 (en) 2009-03-12
CN101820869B (zh) 2012-12-12
WO2009032870A2 (en) 2009-03-12
US9028887B2 (en) 2015-05-12
KR20100075468A (ko) 2010-07-02
CA2698661A1 (en) 2009-03-12
US20120035272A1 (en) 2012-02-09
JP5608082B2 (ja) 2014-10-15
HK1185257A1 (zh) 2014-02-14
US20140256827A1 (en) 2014-09-11
AU2008296293A1 (en) 2009-03-12
CA2698661C (en) 2016-03-29
US8809400B2 (en) 2014-08-19
ES2526648T3 (es) 2015-01-14
JP2010538077A (ja) 2010-12-09
CN103083288A (zh) 2013-05-08
CN101820869A (zh) 2010-09-01
BRPI0816317A2 (pt) 2017-07-25
EP2200597A2 (en) 2010-06-30
WO2009032870A3 (en) 2009-05-22
EP2200597A4 (en) 2010-09-08
EP2200597B1 (en) 2014-11-12

Similar Documents

Publication Publication Date Title
HK1185257A1 (zh) 通過施用紫檀芪減輕氧化應激並改善工作記憶的方法
GB2467083B (en) Power slips
GB2454089B (en) Improvements in or relating to footwear
EP2361340A4 (en) SEAL TRIM
EP2234520A4 (en) IMPROVEMENTS IN AND IN CONNECTION WITH JALOUSIA
EP2315600A4 (en) COMPOSITIONS AND METHODS RELATING TO SIRT1 FUNCTION
GB2460474B (en) Large bore packer
GB0715013D0 (en) Compactor
GB0822690D0 (en) Compactor
GB2458317B (en) Improvements in or relating to ties
GB2459076B (en) Improvements in and relating to medical devices
GB0708628D0 (en) Compactor
EP2126817A4 (en) USE OF SCENARIO-RELATED METADATA FOR DIRECTED ADVERTISING
PL2235261T3 (pl) Podpora podkładu
EP2127181A4 (en) METHOD AND ARRANGEMENT RELATING TO TELECOMMUNICATIONS
GB0711469D0 (en) Improvements in or relating to devices
GB0705482D0 (en) Improvements in and relating to stress
GB2451157B (en) Improvements in or relating to mattresses
GB0817784D0 (en) Hydraulic cylinder and related arrangements
GB2454893B (en) Improvements to lintels
GB0711633D0 (en) Improvements in or relating to wellbore operations
GB2447956B (en) Improvements in or relating to glazing bars
GB0814100D0 (en) 1 to 1
AU2007906583A0 (en) Improvements in or relating to thickeners
GB0711468D0 (en) Improvements in or relating to devices